证券记录 · 已归档季度
CPRX
Catalyst Pharmaceuticals, Inc. · Healthcare · Biotechnology
13被追踪持有人
+3Δ持有人
9.07M持有股份
$180.23M报告持仓市值
+4新建仓位
−1清仓
动量输入（同类管理人）：
持有人广度 +30.0% ·
股份流向 -2.4% ·
净新建仓位 +20.0%
— 公式
持股分散化 — 持有人增多，合计持仓比例缩小
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q3 2024
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 109 | -4 | 77.02M | $2.42B | +12 | −16 |
| Q1 2026 | 116 | +4 | 78.68M | $1.95B | +8 | −4 |
| Q4 2025 | 111 | 0 | 78.17M | $1.82B | — | — |
| Q3 2025 | 19 | 0 | 48.11M | $947.78M | — | −1 |
| Q2 2025 | 17 | +1 | 43.29M | $939.35M | +1 | — |
| Q1 2025 | 13 | -1 | 14.99M | $363.56M | — | −1 |
| Q4 2024 | 14 | 0 | 15.06M | $314.25M | +1 | −1 |
| Q3 2024 | 13 | +3 | 9.07M | $180.23M | +4 | −1 |
| Q2 2024 | 10 | — | 9.29M | $143.84M | — | — |
持有人 · Q3 2024
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Geode Capital Management ✦ (被动) | 2.66M | -1.3% | $52.98M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 2 | Geode Capital Management ✦ (被动) | 2.66M | -1.3% | $52.98M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 3 | Renaissance Technologies ✦ | 2.53M | +16.1% | $50.22M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 4 | T. Rowe Price ✦ | 1.23M | +0.1% | $24.54M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 5 | T. Rowe Price ✦ | 1.23M | +0.1% | $24.54M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 6 | Marshall Wace ✦ | 860.93K | -29.4% | $17.12M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 7 | Millennium Management ✦ | 559.77K | +331.2% | $11.13M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 8 | AQR Capital Management ✦ | 459.35K | -5.9% | $9.13M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 9 | AQR Capital Management ✦ | 459.35K | -5.9% | $9.13M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 10 | AQR Capital Management ✦ | 459.35K | -5.9% | $9.13M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 11 | Arrowstreet Capital ✦ | 301.65K | 新增 | $6.00M | 0.0% | New | 1 | SEC ↗ |
| 12 | Two Sigma Investments ✦ | 159.31K | 新增 | $3.17M | 0.0% | New | 1 | SEC ↗ |
| 13 | Norges Bank ✦ (被动) | 91.77K | 新增 | $1.82M | 0.0% | New | 1 | SEC ↗ |
| 14 | Fisher Asset Management ✦ | 86.80K | -17.8% | $1.73M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 15 | Wellington Management ✦ | 59.58K | 新增 | $1.18M | 0.0% | New | 1 | SEC ↗ |
| 16 | Wellington Management ✦ | 59.58K | 新增 | $1.18M | 0.0% | New | 1 | SEC ↗ |
| 17 | Wellington Management ✦ | 59.58K | 新增 | $1.18M | 0.0% | New | 1 | SEC ↗ |
| 18 | Wellington Management ✦ | 59.58K | 新增 | $1.18M | 0.0% | New | 1 | SEC ↗ |
| 19 | Gotham Asset Management ✦ | 36.14K | +7.2% | $718,483 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 20 | Citadel Advisors ✦ | 25.24K | -95.7% | $501,731 | 0.0% | ▼ Trim | 2 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| Arrowstreet Capital | $6.00M | 0.0% |
| Two Sigma Investments | $3.17M | 0.0% |
| Norges Bank | $1.82M | 0.0% |
| Wellington Management | $1.18M | 0.0% |
| Wellington Management | $1.18M | 0.0% |
| Wellington Management | $1.18M | 0.0% |
| Wellington Management | $1.18M | 0.0% |
已清仓
| Point72 Asset Management | $9.58M | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 378 持有人, 103.75M 股份, $2.50B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q3 2024 ·
方法论 ·
通过API获取此数据